John Towns
Advertisement
John Towns is the senior director of global CMC regulatory affairs at Eli Lilly and Company. Towns is also the chair of the Quality by Design Working Group of the PhRMA Biologics and Biotechnology Leadership Committee
Articles by John Towns
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
Meeting Global Demand and Delivering Faster, More Reliable Service
2
Streamlining Procurement and Inventory Management Leads to Increased Productivity
3
A Strategic Assessment Tool for Modernizing Buffer Preparation in Biologics Facilities
4
Managing Risk and Minimizing the Complexity of Your Global Single-Use Supply Chain
5
